Marie Briden, MD
Dermatology · Edina, MNNPI 1548235872
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $1,270 of the $1,869 with a category attached, or 67.9%. 18 manufacturers reported payments, led by Senseonics, Incorporated at 42.8% of the total. Reporting peaked in 2024 at $1,399 and has fallen 94.7% since, to $74 in 2025.
Across 43 payments — averaging $43.48 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Senseonics, Incorporated$800
- AbbVie$553
- Sanofi$86
- Bsn Medical Inc$70
- Regeneron Healthcare Solutions, Inc.$68
- Amgen$50
- plus $243 from 12 others
What the payments were for
- Speaking & faculty fees$1,27068%
- Food & beverage$57631%
- Education$231%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Senseonics, Incorporated | 2 | $800 |
| AbbVie(2 entities) | 10 | $553 |
| Sanofi | 5 | $86 |
| Bsn Medical Inc | 1 | $70 |
| Regeneron Healthcare Solutions, Inc. | 4 | $68 |
| Amgen | 3 | $50 |
| Incyte Corporation | 2 | $33 |
| Johnson & Johnson | 2 | $29 |
| Arcutis Biotherapeutics, Inc. | 2 | $27 |
| Verrica Pharmaceuticals Inc. | 2 | $27 |
| Galderma Laboratories, L.p. | 2 | $24 |
| Biocon Biologics Inc | 1 | $20 |
| Biofrontera Inc. | 2 | $16 |
| Ascensia Diabetes Care US Inc. | 1 | $14 |
| Sun Pharmaceutical Industries Inc. | 1 | $14 |
| LEO Pharma Inc. | 1 | $13 |
| Genentech USA, Inc. | 1 | $13 |
| Lilly USA, LLC | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Eversense$800
How this compares
$1,869 in reported general payments places this provider in the 85th percentile of 273 dermatology providers in Minnesota.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Clobetasol Propionate | 87 | $2,728 |
| Metronidazole | 33 | $2,431 |
| Betamethasone Dipropionate | 71 | $2,139 |
| Mometasone Furoate | 90 | $1,866 |
| Ketoconazole | 105 | $1,427 |
| Fluocinonide | 32 | $1,222 |
| Minocycline Hcl | 36 | $1,024 |
| Clindamycin Phosphate | 24 | $877 |
| Betamethasone Diprop AugmentedBetamethasone/Propylene Glyc | 16 | $840 |
| Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip | 28 | $616 |
| Desonide | 23 | $496 |
| Mupirocin | 60 | $416 |
| Imiquimod | 18 | $414 |
| ValacyclovirValacyclovir Hcl | 14 | $335 |
| Ciclopirox | 13 | $251 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Edina
- Mimi ChoEdina$2K
- Arthur IdeEdina$1K
- Michelle BussmannEdina$1K
- Kristina ShafferEagan$538K
- Margareth Pierre-LouisMinneapolis$439K
- Maria HordinskyMinneapolis$85K
- Afsaneh AlaviRochester$71K
- Todd SeelhammerSaint Paul$63K
- Brittney SchultzMinneapolis$52K
- David PearsonMinneapolis$46K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.